{"id":"19787557","title":"NAMSYS INC. Announces Normal Course Issuer Bid","author":null,"feed":"PRTGAM","feedName":"Newswire.ca","published":"Tue Aug 29, 2023","image":"N/A","content":"

TORONTO, Aug. 29, 2023 /CNW/ - NamSys Inc. (TSX-V: CTZ) announced today that the TSX Venture Exchange (the "Exchange") has accepted a notice filed by NamSys Inc. (the "Company") of its intention to make a Normal Course Issuer Bid (the "Bid") to be transacted through the facilities of the Exchange.

","related":[{"id":"740080","title":"Corvus’ Soquelitinib Trial Completion Adds a New Catalyst in the Atopic Dermatitis Market","slug":"corvus-soquelitinib-trial-completion-adds-a-new-catalyst-in-the-atopic-dermatitis-market","feedName":"Tipranks","published":"8 minutes ago","categories":[]},{"id":"740078","title":"Edgewise Therapeutics Completes Key Renal Study for EDG-7500, Setting Up Next Steps for Investors","slug":"edgewise-therapeutics-completes-key-renal-study-for-edg-7500-setting-up-next-steps-for-investors","feedName":"Tipranks","published":"8 minutes ago","categories":[]},{"id":"740076","title":"Novo Nordisk Maps Global Awareness of Metabolic Liver Disease With ACT on MASH Study","slug":"novo-nordisk-maps-global-awareness-of-metabolic-liver-disease-with-act-on-mash-study","feedName":"Tipranks","published":"8 minutes ago","categories":[]},{"id":"740074","title":"Ocuphire’s Nyxol Presbyopia Trial Nears Data: What Investors Should Watch","slug":"ocuphires-nyxol-presbyopia-trial-nears-data-what-investors-should-watch","feedName":"Tipranks","published":"8 minutes ago","categories":[]},{"id":"740072","title":"Viatris-Backed Nyxol Trial Completes Phase 3, Setting Up a Key Night-Vision Catalyst","slug":"viatris-backed-nyxol-trial-completes-phase-3-setting-up-a-key-night-vision-catalyst","feedName":"Tipranks","published":"8 minutes ago","categories":[]},{"id":"740103","title":"Bybit Brings Regulators and Global Payment Leaders Together in Georgia to Explore the Future of Crypto Payments","slug":"bybit-brings-regulators-and-global-payment-leaders-together-in-georgia-to-explore-the-future-of-crypto-payments","feedName":"Newswire.ca","published":"8 minutes ago","categories":[]},{"id":"740070","title":"Moderna’s Multi-Pathogen mRNA Study Reaches Completion, Supporting a Broader Vaccine Platform","slug":"modernas-multi-pathogen-mrna-study-reaches-completion-supporting-a-broader-vaccine-platform","feedName":"Tipranks","published":"8 minutes ago","categories":[]},{"id":"740068","title":"Bavarian Nordic’s Phase 3b Chikungunya Vaccine Trial Sets Up a New Catalyst for BVNRY Investors","slug":"bavarian-nordics-phase-3b-chikungunya-vaccine-trial-sets-up-a-new-catalyst-for-bvnry-investors","feedName":"Tipranks","published":"8 minutes ago","categories":[]},{"id":"740066","title":"Hunting PLC Publishes 2025 Annual Report and Sets Date for 2026 AGM","slug":"hunting-plc-publishes-2025-annual-report-and-sets-date-for-2026-agm","feedName":"Tipranks","published":"8 minutes ago","categories":[]}],"sourceId":"newswireca-2023-8-29-namsys-inc-announces-normal-course-issuer-bid","media":"text","thumbnail":"N/A","canonicalUrl":"https://www.newswire.ca/news-releases/namsys-inc-announces-normal-course-issuer-bid-886162620.html","feedUrl":null,"slug":"namsys-inc-announces-normal-course-issuer-bid"}

Latest in

More

NAMSYS INC. Announces Normal Course Issuer Bid